Literature DB >> 7352974

Biosynthesis of interstitial types of collagen by albumin-producing rat liver parenchymal cell (hepatocyte) clones in culture.

R Hata, Y Ninomiya, Y Nagai, Y Tsukada.   

Abstract

We have analyzed collagenous components produced by an albumin-producing rat liver parenchymal cell clone (BB) in culture. The cells secreted over 90% of the [3H]proline-labeled collagenous components into the medium after 18 h of incubation in vitro. Analysis of the components by sodium dodecyl sulfate-polyacrylamide gell electrophoresis and by carboxymethylcellulose chromatography of cyanogen bromide peptides after separation of individual collagen chains showed that the cells produced type I, type I trimer, and type II collagens in the ration 59:29:4. These components account for over 90% of the collagen isolated. Type I and type I trimer collagens were present in both the medium and cell layer fractions, but type III collagen was found solely in the medium. The cells also produced other minor collagenous components, one of which was quite similar to type V collagen. Analysis of collagen components produced by another liver parenchymal cell clone (BC) and by three subclones derived from BB cells showed that these cloned cells synthesized similar types of collagen. These results support the idea that parenchymal cells play an essential role in the heaptic connective tissue metabolism under normal and pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7352974     DOI: 10.1021/bi00542a026

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  An osteonectin-like protein in the matrix of cultured osteogenic cell-line MC3T3-E1, which is associated with calcification.

Authors:  M Mizuno; H Y Zhou; H Yamada; M Kawamura; H Hirano; Y Kuboki
Journal:  Calcif Tissue Int       Date:  1992-08       Impact factor: 4.333

2.  In vitro analysis of extracellular matrix production by porcine glomerular mesangial and vascular smooth muscle cells.

Authors:  Y Y Chiang; S Takebayashi; T D Oberley
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

3.  DNA methylation inhibits transcription of procollagen alpha 2(I) promoters.

Authors:  D K Guenette; J D Ritzenthaler; J Foley; J D Jackson; B D Smith
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

4.  De-differentiation of primary human hepatocytes depends on the composition of specialized liver basement membrane.

Authors:  Michael Zeisberg; Kyle Kramer; Nazia Sindhi; Pradip Sarkar; Melissa Upton; Raghu Kalluri
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

5.  Methylation of the alpha 2(I) collagen gene in chemically transformed rat liver epithelial cells.

Authors:  B D Smith; E Marsilio
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

6.  Modulation of collagen synthesis by fat-storing cells, isolated from CCl4- or vitamin A-treated rats.

Authors:  Y Shiratori; T Ichida; A Geerts; E Wisse
Journal:  Dig Dis Sci       Date:  1987-11       Impact factor: 3.199

7.  Ultrastructure of initial stages of perivenular fibrosis in alcohol-fed baboons.

Authors:  M Nakano; C S Lieber
Journal:  Am J Pathol       Date:  1982-02       Impact factor: 4.307

Review 8.  Connective tissue components of the normal and fibrotic liver. I. Structure, local distribution and metabolism of connective tissue components in the normal liver and changes in chronic liver diseases.

Authors:  J Rauterberg; B Voss; G Pott; U Gerlach
Journal:  Klin Wochenschr       Date:  1981-07-15

9.  Sequential changes of extracellular matrix and proliferation of Ito cells with enhanced expression of desmin and actin in focal hepatic injury.

Authors:  K Ogawa; J Suzuki; H Mukai; M Mori
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

10.  Immunohistochemical localization of collagenous proteins in cartilaginous tumors: characteristic distribution of type IX collagen.

Authors:  A Kawashima; Y Ueda; H Tsuchiya; K Tomita; Y Nagai; I Nakanishi
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.